Work

Efficacy and safety of immune checkpoint inhibitors in advanced or recurrent endometrial cancer: individual patient data and trial-level meta-analysis

Year: 2027
Type: article
Abstract: Objective Whether immune checkpoint inhibitor (ICI)-based regimens confer a survival benefit over chemotherapy (CT) alone in advanced/recurrent endometrial cancer (EC), particularly by mismatch repair status, remains inconclusive. We conducted an individual patient data (IPD) meta-analysis of randomized trials comparing ICI-based regimens vs. CT alone to quantify survival benefits and assess safety.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7234720684
Cites: 36
Cited by:
Related to: 10